Recent articles

• ON101 Named Among the Global Top 15 in the ADA 2026 Innovation Challenge 2026-05-29
• Bonvadis® topical cream received medical device marketing authorization approval for all indications in wounds by Health Canada. 2026-05-11
• Bonvadis® topical cream received medical device marketing authorization approval for all indications in wounds by ThaiFDA. 2026-05-11
• Bonvadis® topical cream received medical device marketing authorization approval for all indications in wounds by AMMPS Morocco. 2026-04-10
• EU NB issued the EU market approval for Bonvadis® that grants marketing authorization across all 27 EU member states for acute and chronic wounds, and scar management. 2026-03-12
• Bonvadis® topical cream received medical device marketing authorization approval for all indications in wounds by INVIMA Colombia. 2026-02-22
• The medical device registration application of Bonvadis® for all indications of wounds has been accepted by INVIMA Colombia. 2026-01-31